What are the AUA treatment guidelines for symptomatic, metastatic castration-resistant prostate cancer (CRPC) with poor performance status and prior docetaxel chemotherapy?

Updated: Jul 31, 2017
  • Author: Bagi RP Jana, MD; more...
  • Print


Recommendations are as follows:

  • Palliative care

  • For selected patients, offer treatment with abiraterone plus prednisone, enzalutamide, ketoconazole plus steroid, or radionuclide therapy

  • Systemic chemotherapy or immunotherapy should not be offered

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!